Pharmacology of Asthma (Handbook of Experimental Pharmacology. Continuation of Handbuch der experimentellen Pharmakologie, Vol. 98) - copertina rigida, flessible

EAN (ISBN-13): 9783540528395
ISBN (ISBN-10): 3540528393
Copertina rigida
Anno di pubblicazione: 1991
Editore: Springer

Libro nella banca dati dal 2010-08-01T14:06:18+02:00 (Rome)
Pagina di dettaglio ultima modifica in 2023-05-26T13:01:20+02:00 (Rome)
ISBN/EAN: 3540528393

ISBN - Stili di scrittura alternativi:
3-540-52839-3, 978-3-540-52839-5
Stili di scrittura alternativi e concetti di ricerca simili:
Autore del libro : szczeklik, goldie peter, peter garland, alexander schmitz, chung, kay barnes, peter schumann, pauwels, page smith, lulich, virchow, wilson peter, persson, lülich
Titolo del libro: handbook experimental pharmacology, asthma, hand

---

Dati dell'editore

Autore: Clive P. Page; Peter J. Barnes
Titolo: Handbook of Experimental Pharmacology; Pharmacology of Asthma
Editore: Springer; Springer Berlin
320 Pagine
Anno di pubblicazione: 1991-02-28
Berlin; Heidelberg; DE
Peso: 0,725 kg
Lingua: Inglese
85,55 € (DE)
87,95 € (AT)
106,60 CHF (CH)
Not available, publisher indicates OP

BB; Book; Hardcover, Softcover / Medizin/Pharmazie; Pharmakologie; Verstehen; Atemwegeerkrankung; Atmen; asthma; physiology; pathophysiology; B; Pharmacology/Toxicology; Biomedical and Life Sciences; Allergology; Immunology; Pneumology/Respiratory System; Pathology; Human Physiology; Medizin: Allergien; Immunologie; Lungen- und Bronchialheilkunde; Pathologie; Physiologie; BC; EA

1 The Pathology of Asthma: An Overview.- A. Introduction.- B. Methods to Investigate the Pathology of Human Asthma.- C. Bronchial Epithelium and Inflammatory Cells in Asthmatic Patients Between Attacks.- I. Mast Cells.- II. Eosinophils.- III. Neutrophils.- D. Bronchial Epithelial Inflammation During an Asthma Attack.- E. Epithelial Regeneration.- F. Airway Smooth Muscle.- G. Bronchial Glands.- H. Neural Pathways.- I. Epithelium.- II. Neuroepithelial Bodies and Neuroendocrine-Like (Granule-Containing) Cells.- I. Nerves and Other Airway Structures.- J. Bronchial Circulation.- K. Leakage of the Bronchial Vascular Bed in Patients with Asthma.- L. Conclusion.- References.- 2 The Contribution of Inflammatory Cells to the Pathogenesis of Asthma.- A. Inflammation and Inflammatory Cells.- B. Pathological Evidence for Inflammation in Asthma.- C. Microvascular Leakage.- D. Neutrophils.- E. Eosinophils.- F. Mast Cells and Basophils.- G. Monocytes and Macrophages (Mononuclear Phagocytes).- H. Platelets.- I. Lymphocytes.- J. Concluding Comments.- References.- 3 Inflammatory Mediators.- A. Introduction.- I. Cellular Origin of Mediators.- II. Mediator Effects.- III. Mediator Receptors.- IV. Mediator Interactions.- V. Mediator Antagonists.- B. Histamine.- I. Synthesis and Metabolism.- II. Histamine Receptors.- III. Airway Effects.- IV. Role in Asthma.- C. Cyclooxygenase Products.- I. Synthesis and Metabolism.- II. Receptors.- III. Airway Effects.- 1. Airway Smooth Muscle.- 2. Secretion.- 3. Inflammatory Effects.- IV. Role in Asthma.- D. Lipoxygenase Products.- I. Synthesis and Metabolism.- II. Receptors.- III. Airway Effects.- 1. Airway Smooth Muscle.- 2. Secretion.- 3. Vascular Effects.- 4. Cellular Activation.- 5. Effects on Bronchial Responsiveness.- IV. Role in Asthma.- E. PAF.- I. Origin.- 1. Synthesis.- 2. Cellular Origin.- 3. Metabolism.- II. Receptors.- III. Airway Effects.- 1. Airway Smooth Muscle.- 2. Airway Secretions.- 3. Vascular Effects.- 4. Inflammatory Cell Activation.- 5. Bronchial Hyperresponsiveness.- IV. Role in Asthma.- 1. Release of PAF in Asthma.- 2. PAF Antagonists.- F. Kinins.- I. Formation and Metabolism.- II. Receptors.- III. Airway Effects.- IV. Role in Asthma.- G. Adenosine.- I. Origin.- II. Receptors.- III. Actions.- IV. Role in Asthma.- H. Complement.- I. Origin and Metabolism.- II. Receptors.- III. Airway Effects.- 1. Smooth Muscle Contraction.- 2. Vascular Effects.- 3. Mucus Secretion.- 4. Chemotaxis and Cell Activation.- 5. Bronchial Hyperresponsiveness:.- IV. Role in Asthma.- I. Serotonin.- I. Origin.- II. Receptors.- III. Airway Effects.- J. Chemotactic Factors.- K. Oxygen Radicals.- L. Conclusions.- References.- 4 Pharmacology of Airway Smooth Muscle.- A. Introduction.- B. E/C Coupling Mechanisms.- I. The Airway Smooth Muscle Cell.- II. Activator Calcium Ions and E/C Coupling.- 1. Coupling Mechanisms.- 2. Extracellular Activator Ca2+.- 3. Intracellular Activator Ca2+.- III. Biochemical Basis of Airway Smooth Muscle Contraction.- C. E/C Uncoupling Mechamisms.- I. ?-Adrenoceptor Agonists.- 1. ?-Agonist-Induced Relaxation In Vitro: General Properties.- 2. Role of Cyclic Adenosine Monophosphate (cAMP) Accumulation in the Relaxant Actions of ?-Adrenoceptor Agonists.- 3. ?-Agonists and the Ca2+ Sensitivity (or Responsiveness) of the Contractile Machinery.- 4. ?-Agonists and Inhibition of Ca2+ Influx.- 5. ?-Agonists and Inhibition of Ca2+ Release from Intracellular Stores.- 6. ?-Agonists and Promotion of Ca2+ Sequestration by Intracellular Stores.- 7. ?-Agonists and Ca2+ Extrusion.- II. Alkylxanthines.- 1. Alkylxanthine-Induced Relaxation In Vitro: General Properties.- 2. Role of cAMP Accumulation in the Relaxant Actions of Alkylxanthines..- 3. Alkyxanthines and Reduction in the Ca2+ Sensitivity (or Responsiveness) of the Contractile Machinery.- 4. Alkylxanthines and Inhibition of Ca2+ Influx.- 5. Alkylxanthines and Inhibition of Ca2+ Release from Intracellular Stores.- 6. Alkylxanthines and Promotion of Ca2+ Sequestration by Intracellular Stores.- 7. Alkylxanthines and Ca2+ Extrusion.- D. Future Trends in the Development of Bronchodilator Drugs.- References.- 5 Neural Mechanisms in Asthma.- A. Introduction.- B. Cholinergic Mechanisms.- I. Increased Vagal Tone.- II. Reflex Bronchoconstriction.- III. Increased Acetylcholine Release.- IV. Muscarinic Receptors.- V. Cholinergic Mechanisms in Asthma.- VI. Cholinergic Mechanisms in COAD.- VII. Muscarinic Receptor Subtypes.- C. Adrenergic Mechanisms.- I. Adrenergic Innervation.- II. Circulating Catecholamines.- III. ?-Adrenoceptors.- IV. ?-Adrenoceptors.- D. NANC Nerves and Neuropeptides.- I. NANC Inhibitory Nerves.- II. Increased NANC Excitatory Nerves.- III. Tachykinins.- IV. Calcitonin Gene-Related Peptide.- V. Axon Reflex Mechanisms.- VI. Modulation of NANC Bronchoconstriction.- E. Conclusions.- References.- 6 Pharmacology and Therapeutics of ?-Adrenoceptor Agonists.- A. Introduction.- B. The Molecular Nature of the ?-Adrenoceptor and Its Relationship to Adenylate Cyclase.- I. The ?-Adrenoceptor.- II. Regulatory Proteins.- III. Adenylate Cyclase.- IV. ?-Adrenoceptor Desensitization.- C. Density and Distribution of ?-Adrenoceptors in the Lung.- I. Radioligand Binding Studies.- II. Autoradiography.- 1. Trachea.- 2. Parenchyma.- D. Therapeutic Sites of Action.- I. Airway Smooth Muscle.- II. Secretory Cells and Cilia.- III. Tracheobronchial Microvessels.- IV. Cholinergic Nerves.- V. Mast Cells.- VI. Inflammatory Cells.- 1. Eosinophils.- 2. Lymphocytes.- 3. Polymorphonuclear Leukocytes.- 4. Macrophages.- 5. Platelets.- 6. Anti-Inflammatory Action in Asthmatic Airways.- E. The Status of ?-Adrenoceptor Function in Asthma.- I. In Vivo Studies.- II. In Vitro Studies.- 1. Isolated Human Leukocytes.- 2. Isolated Human Bronchi.- 3. Radioligand Binding Studies and Autoradiography in Lung.- F. The Importance of ?2-Adrenoceptor Selectivity and Efficacy.- I. ?2 Selectivity.- II. Efficacy.- G. Adverse Reactions to ?-Adrenoceptor Agonists.- I. Skeletal Muscle Tremor.- II. Cardiac Effects.- III. Changes in Plasma Constituents.- 1. Potassium.- 2. Glucose.- 3. Lipids.- IV. PaO2.- V. Neuropharmacological Effects.- VI. Hypersensitivity.- H. Therapeutic Actions of ?-Agonists.- I. Adrenaline.- II. Ephedrine.- III. Isoprenaline.- IV. Selective ?2-Agonists.- V. Prodrugs.- VI. Clinical Application.- I. Concluding Remarks.- References.- 7 Pharmacology of Anti-Asthma Xanthines.- A. Introduction.- I. Developmental Aspects.- II. Chemistry and Subdivision of Xanthines.- B. Clinical Use.- I. Acute Severe Asthma.- II. Chronic Asthma.- III. Chronic Obstructive Pulmonary Disorders.- C. Mode of Action of Xanthines.- I. Smooth Muscle Relaxation or Inhibition?.- II. Airway Anti-Inflammatory Actions.- III. Anti-Asthma Actions Outside the Airways?.- IV. Subcellular Mechanisms of Action.- V. Role of Endogenous Adenosine.- D. Conclusion.- References.- 8 Glucocotricosteroids in Asthma.- A. Mechanism of Action of Glucocorticosteroids.- I. Induction of Protein Synthesis.- 1. Lipocortins.- 2. Other Proteins Modulated by Glucocorticosteroids.- II. Effects on Cell Activation and Recruitment.- III. Other Effects.- 1. Vascular Permeability and Effects on Vascular Endothelium.- 2. Effects on ?-Adrenoceptors.- 3. Effects on Airway Function.- B. Clinical Use.- I. Pharmacokinetics of Steroids.- II. Routes of Administration.- 1. Oral.- 2. Intravenous.- 3. Inhaled.- III. Side Effects.- 1. Adrenal Suppression.- 2. Systemic Side Effects.- 3. Local Side Effects.- IV. Use in Clinical Practice.- 1. Acute Asthma.- 2. Chronic Asthma.- C. Future Developments.- References.- 9 Pharmacology of Prophylactic Anti-Asthma Drugs.- A. Cromoglycate and Nedocromil.- I. Cellular Pharmacology.- 1. Mast Cells and Basophils.- 2. Neutrophils, Eosinophils, Monocytes, and Platelets.- II. Biochemical Pharmacology.- III. Animal Pharmacology.- 1. Anaphylactic Bronchospasm.- 2. Sensory Reflexes.- IV. Human Pharmacology.- B. Ketotifen.- I. Pharmacology In Vitro.- II. Animal Pharmacology.- 1. Antihistamine, Antiallergic Properties.- 2. Inhibition of PAF-Induced Airway Hyperreactivity.- III. Human Pharmacology.- 1. Blockade of Responses to Spasmogens and Allergens.- 2. Reversal of ?-Adrenergic Receptor Tachyphylaxis.- 3. Double-Blind Placebo-Controlled Clinical Trials.- C. Pharmacological Analysis.- I. Cromoglycate and Nedocromil.- II. Ketotifen.- References.- 10 Pathophysiology and Pharmacology of Aspirin-Induced Asthma.- A. Introduction.- B. Definition and Main Clinical Features.- I. Major Offenders and Safe Alternatives.- II. Salicylates.- III. Paracetamol.- IV. Pyrazolones.- V. Tartrazine.- VI. Glucocorticosteroids.- C. Pathogenesis.- I. Allergic Mechanisms.- II. Abnormal Reactivity of Bradykinin Receptors.- III. Acetylation of Proteins.- IV. Complement Involvement.- V. The Cyclooxygenase Theory.- 1. Formulation of the Theory.- 2. Early Explanations.- 3. Participation of LTs.- 4. Platelet Involvement.- 5. Compartmentalization of Eicosanoids in the Lungs.- 6. Viral Infection.- D. Diagnosis.- E. Prevention and Therapy.- References.
This volume reviews in depth our current understanding of the mechanisms and treatment of asthma. The volume brings together recognised international authorities and is extensively referenced. It will provide an invaluable reference source for scientists, chest physicians and others with an interest in asthma.